Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2026-04-08 21:55:04 ET · period of report 2026-03-20 · accession 0001193125-26-148614 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-08 21:55 | 2026-03-20 | LAB | Mackay Sean | SVP, Chief Business Off | A - Grant | $0.00 | +272.1K | 1.03M | +36% | $0 |
| D | 2026-04-08 21:55 | 2026-03-20 | LAB | Mackay Sean | SVP, Chief Business Off | A - Grant | $0.00 | +612.2K | 612.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-20 | A | A | 272,107 | $0.00 | 1,032,281 | D | — | — | (F1) Represents restricted stock units ("RSUs") that vest over four years, with 1/16 of the RSUs vesting on May 20, 2026 and the remaining RSUs vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. |
| 2 | Derivative | Stock Option (Right to buy) | 2026-03-20 | A | A | 612,240 | $0.00 | 612,240 | D | $0.9846 · — to 2036-03-20 | 612,240 Common Stock | (F2) The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2026, with the remaining shares vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. |